Brief: Medlive Technology Sees Rise In Profit Attributable For FY2022 Not Less Than RMB100 Mln
March 2 (Reuters) - Medlive Technology Co Ltd 2192.HK :
* MEDLIVE TECHNOLOGY CO LTD SEES INCREASE IN PROFIT
ATTRIBUTABLE
FOR FY2022 TO NOT LESS THAN RMB100 MILLION
* EXPECTS TO RECORD AN INCREASE IN REVENUE FOR FY2022 OF
AROUND
10%
* EXPECTED REVENUE DUE TO INCREASE IN REVENUE FROM GROUP'S
PRECISION MARKETING AND CORPORATE SOLUTIONS.
* EXPECTED RESULT DUE TO SIGNIFICANT INCREASE IN INTEREST
INCOME
IN FY2022, AMONG OTHERS
Further company coverage: 2192.HK
Recent news on Medlive Technology Co
See all newsBrief: Medlive Technology Posts Full-Year Revenue Of RMB 642.2 Million
Brief: Medlive Technology Logs H1 Adjusted Net Income RMB166.7 Mln
Brief: Medlive Technology Posts FY Adjusted Net Income Of RMB323.6 Million
Brief: Medlive Technology Declares Interim Dividend Of RMB12.05 Cents Per Ordinary Share
Brief: Medlive Technology Posts H1 Adjusted Net Income RMB 156 Million